Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

YM-905 shows promising activity in animal model of IBS

April 6, 1998

Eisai files NDA for Aciphex, novel treatment for GERD and ulcers

April 3, 1998

Novel 5-HT4 agonist in development at Yoshitomi for GI motility disorders

April 1, 1998

Toyama's T-593 associated with improved quality of ulcer healing compared to other H2 blockers

April 1, 1998

Taisho's H2 antagonist displays potent antiulcer activity in preclinical models

March 31, 1998

KW-5617: a calmodulin inhibitor with antidiarrheal activity

March 31, 1998

Glaxo Wellcome files for European approval of lamivudine in HBV

March 26, 1998

IL-10 in clinical testing for multiple indications at Schering-Plough

March 26, 1998

Phase II trial begins with rPAF-AH in pancreatitis

March 17, 1998

Intercardia to license IBD drug

March 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...